UnitedHealth Group (UNH) Price Target Increased to $260.00 by Analysts at Credit Suisse Group

UnitedHealth Group (NYSE:UNH) had its target price boosted by investment analysts at Credit Suisse Group from $252.00 to $260.00 in a research report issued on Wednesday. The brokerage currently has an “outperform” rating on the healthcare conglomerate’s stock. Credit Suisse Group’s price objective points to a potential upside of 11.64% from the stock’s previous close.

Several other equities research analysts have also commented on UNH. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective for the company in a research note on Thursday, September 21st. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Sanford C. Bernstein restated an “outperform” rating and issued a $210.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, October 10th. Jefferies Group upped their price objective on UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a research note on Friday, October 13th. Finally, BMO Capital Markets started coverage on UnitedHealth Group in a research note on Monday, October 16th. They issued an “outperform” rating and a $250.00 price objective for the company. Three research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $239.70.

UnitedHealth Group (NYSE:UNH) traded up $4.26 during midday trading on Wednesday, hitting $232.90. The stock had a trading volume of 6,852,400 shares, compared to its average volume of 3,225,820. The company has a market cap of $230,080.00, a PE ratio of 21.75, a price-to-earnings-growth ratio of 1.53 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group has a 12-month low of $156.09 and a 12-month high of $235.00.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. UnitedHealth Group’s revenue was up 9.5% on a year-over-year basis. During the same period in the prior year, the business posted $2.11 EPS. analysts expect that UnitedHealth Group will post 9.99 EPS for the current fiscal year.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the sale, the director now owns 61,137 shares in the company, valued at approximately $13,652,503.47. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the sale, the chief executive officer now owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. Insiders sold a total of 34,630 shares of company stock valued at $7,669,416 in the last quarter. 0.89% of the stock is currently owned by company insiders.

A number of hedge funds have recently modified their holdings of the business. Blue Chip Partners Inc. purchased a new position in shares of UnitedHealth Group during the second quarter valued at about $110,000. Bruderman Asset Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter valued at about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its position in shares of UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares in the last quarter. BDO Wealth Advisors LLC purchased a new position in shares of UnitedHealth Group during the second quarter valued at about $121,000. Finally, Acrospire Investment Management LLC grew its position in shares of UnitedHealth Group by 130.7% during the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares in the last quarter. Institutional investors and hedge funds own 86.09% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group (UNH) Price Target Increased to $260.00 by Analysts at Credit Suisse Group” was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another domain, it was stolen and republished in violation of U.S. and international copyright laws. The original version of this news story can be accessed at https://www.americanbankingnews.com/2018/01/17/unitedhealth-group-unh-price-target-increased-to-260-00-by-analysts-at-credit-suisse-group.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Leave a Reply